Clumax Diagnostics Pvt Ltd has installed the MRI-guided High Intensity Focused Ultrasound (HIFU) solution from Philips at its facility at Bashyam Circle, Sadashivnagar in Bangalore.
The Philips MRI Guided HIFU system has been clinically approved for the treatment of non-cancerous tumours like uterine fibroids and malignancies like bone metastases. MRI guided HIFU offers a non-invasive alternative to traditional treatments for uterine fibroids in women.
It combines the precision of Magnetic Resonance Imaging (MRI) to map the fibroids and monitor the treatment with safe ultrasound energy (HIFU) to coagulate and de-naturize the proteins in benign fibroid tissue or cancerous tumour tissue without damaging intervening tissue. In contrast to the existing treatment options of surgery to remove fibroids, MRI-Guided HIFU from Philips offers women a quicker, non-invasive and precise treatment option.
The entire procedure is performed in just a few hours without any hospital admission. The patient can return home from the clinic or hospital the same day and return to a normal life within a couple of days. The benefits for women include – no surgery, no scars, no anaesthesia, no radiation, more precise image guided treatment, no hospital admission, preservation of the uterus, quicker recovery, and lesser stress.
Uterine fibroids are non-cancerous growths of the uterus that often appear during childbearing years. One out of four women have uterine fibroids sometime during their lives, but many are unaware of them because they often cause no symptoms. A doctor may discover them incidentally during a pelvic exam or prenatal ultrasound.
According to Dr Srinivasan Radhesh, chief radiologist, Clumax Diagnostics, MR guided HIFU is a highly precise, safe, radiation-free, non-invasive treatment option and comes as a shot in the arm for women living with fibroids. Being patient friendly treatment, it allows a doctor access to a three-dimensional planning of the procedure and offers real time temperature monitoring during the ablation to control the amount of energy delivered to the tissue by the HIFU system.”
The future of medicine in our view will be image-guided, non-invasive and without radiation, and MRI-HIFU represents the convergence of these 3 principles for improving the lives of women with uterine fibroids and people with malignant tumours. The launch of MRI-HIFU is yet another testimonial to Philips’ commitment to bring cutting-edge innovations to solve key healthcare challenges like tumours that face India, stated Dr Sham Sokka, CTO and director – Research & Clinical Science, Clumax Diagnostics.
“The launch marks the first installation of MRI guided HIFU in Karnataka. Philips’ MRI Guided HIFU has been launched at several leading centres around the world including the National Institutes of Health and the Johns Hopkins Medical Centre in the US,” stated Raveendran Gandhi, Sr. director – Image Guided Therapy, Philips Healthcare, India.
Clumax Diagnostics, a premier hi-tech Diagnostic centre in South Bangalore was acquired by Medall in Feb 2010. It offers comprehensive diagnostic services under one roof from the latest CT, MRI, Nuclear Medicine, Ultrasound & Dopplers, Mammography, X-Rays, Cardiology & Neurology services, Gastroenterology services and Clinical consultation with all Master Health checkups. It is an ISO 9001: 2008 Company and also received the NABL (National Accreditation board for Laboratories) certification recently.